Siga Technologies (SIGA) Return on Capital Employed (2011 - 2025)
Siga Technologies' (SIGA) quarterly Return on Capital Employed came in at 43.28% in Q3 2025, down 1763.0% YoY from 2.6% in Q3 2024, and down 6.43% on a QoQ basis from 46.25% in Q2 2025.
Siga Technologies (SIGA) Return on Capital Employed (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 15 years of Return on Capital Employed data on file, last reported at 43.28% in Q3 2025.
- Quarterly Return on Capital Employed fell 1763.0% year-over-year to 43.28% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 43.28% (down 1763.0% YoY) and the FY2024 annual result came in at 31.24%, down 1778.0% from the prior year.
- Return on Capital Employed slipped to 43.28% in Q3 2025, from 46.25% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 89.59% in Q3 2022 to a low of 8.1% in Q3 2023.
- A 5-year average of 43.35% and a median of 46.25% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 7068 bps — and 2023, when it slumped 9769 bps.
- Tracing SIGA's Return on Capital Employed over 5 years: stood at 61.59% in 2021, then plunged by 61 bps to 23.97% in 2022, then jumped by 129 bps to 54.92% in 2023, then plunged by 34 bps to 35.98% in 2024, then rose by 20 bps to 43.28% in 2025.
- The last three Return on Capital Employed figures came in at 43.28% (Q3 2025), 46.25% (Q2 2025), and 25.91% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 43.28% |
| Jun 30, 2025 | 46.25% |
| Mar 31, 2025 | 25.91% |
| Dec 31, 2024 | 35.98% |
| Sep 30, 2024 | 60.90% |
| Jun 30, 2024 | 52.27% |
| Mar 31, 2024 | 55.77% |
| Dec 31, 2023 | 54.92% |
| Sep 30, 2023 | -8.10% |
| Jun 30, 2023 | 23.47% |
| Mar 31, 2023 | 24.58% |
| Dec 31, 2022 | 23.97% |
| Sep 30, 2022 | 89.59% |
| Jun 30, 2022 | 59.60% |
| Mar 31, 2022 | 46.59% |
| Dec 31, 2021 | 61.59% |
| Sep 30, 2021 | 18.91% |
| Jun 30, 2021 | 45.00% |
| Mar 31, 2021 | 63.24% |
| Dec 31, 2020 | 62.53% |